Aerie has all the hallmarks of a promising early stage biotechnology company, ... Initial animal testing has been very encouraging. Our products target a rapidly growing $3 billion dollar global market that has seen little innovation and is ripe for improvement. We have a seasoned team of senior executives who will successfully shepherd AR-101 into the clinic, and we have provided the necessary capital to get them there.

-David Mack

Select a background
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image

More quotes by David Mack